Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis

M Aitken, M Davidson, MV Chan, C Urzua Fresno… - Radiology, 2023 - pubs.rsna.org
Background There is no consensus regarding the relative prognostic value of cardiac MRI
and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. Purpose To perform a systematic …

EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0

G Abikhzer, G Treglia, M Pelletier-Galarneau… - European Journal of …, 2024 - Springer
Abstract Introduction Hybrid [18F] FDG PET imaging is currently the method of choice for a
wide variety of infectious and inflammatory disorders and was recently adopted in several …

The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies

MS Alfawara, AI Ahmed, JM Saad, Y Han… - European journal of …, 2023 - Springer
Purpose We evaluated whether serum beta-hydroxybutyrate (BHB) can identify adequate
suppression of the left ventricle (LV) among patients undergoing [18F]-fluorodeoxyglucose …

Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges

D Korthals, M Bietenbeck, H Könemann… - Journal of Clinical …, 2024 - mdpi.com
Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves
an antigen-triggered dysregulated T-cell-driven immunologic response leading to non …

Risk stratification in cardiac sarcoidosis with cardiac positron emission tomography: a systematic review and meta-analysis

TS Kafil, OM Shaikh, Y Fanous, J Benjamen… - Cardiovascular …, 2024 - jacc.org
Background Although positron emission tomography (PET) imaging is well established for
its diagnostic role in cardiac sarcoidosis, less is known about the prognostic value of PET …

Cardiac Sarcoidosis

MLR Neto, CL Jellis, PC Cremer… - Clinics in Chest …, 2024 - chestmed.theclinics.com
Cardiac involvement is a major cause of morbidity and mortality in patients with sarcoidosis.
1, 2 Compared with many other manifestations of the disease, patients with cardiac …

Positron emission tomography in heart failure: from Pathophysiology to clinical application

G Tersalvi, V Beltrani, MR Grübler, A Molteni… - Journal of …, 2023 - mdpi.com
Imaging modalities are increasingly being used to evaluate the underlying pathophysiology
of heart failure. Positron emission tomography (PET) is a non-invasive imaging technique …

[HTML][HTML] Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging

M Stjepanovic, F Markovic, I Milivojevic, S Popevic… - Diagnostics, 2024 - mdpi.com
Sarcoidosis is an inflammatory condition that can affect multiple organ systems and is
characterized by the formation of non-caseating granulomas in various organs, including the …

Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT

R Campisi, MF Merani, MI Rodríguez - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cardiac sarcoidosis (CS) is an inflammatory disease of
unknown etiology that can lead to life-threatening arrhythmias, heart failure, and death …